Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,291.34 +7.94 (+0.15%) Dow
38,711.29 +140.26 (+0.36%) Nasdaq
16,857.05 +28.38 (+0.17%) Bitcoin USD
70,735.34 +1,810.74 (+2.63%) CMC Crypto 200
1,503.69 +29.95 (+2.03%)
EW Jan 2025 92.500 call
| Previous close | 6.46 |
| Open | 6.46 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 92.50 |
| Expiry date | 2025-01-17 |
| Day's range | 6.46 - 6.46 |
| Contract range | N/A |
| Volume | |
| Open interest | 425 |
Simply Wall St.Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
Business WireEdwards Lifesciences to Sell Critical Care to BD
IRVINE, CA, June 03, 2024--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.
